Personal profile

Research interests

I am deeply interested in the origins and effects of human metabolic liver disease. My research work specifically targets ‘metabolic dysfunction-associated steatotic liver disease’ (MASLD/NAFLD), which is the leading cause of chronic liver disease globally.

I am motivated by the conviction that only through rigorous and innovative clinical research can we increase our ability to understand and manage chronic conditions. I wish to solve critical questions regarding the bidirectional impact of liver disease on metabolic health and determine how key disease-causal metabolic pathways are driven by acquired and genetic risk factors. In pursuit of this goal, I combine interventional metabolic/nutritional studies with in vivo isotope tracer techniques, advanced imaging modalities, and tissue multi-omic analysis. Additionally, I leverage computer vision to quantitatively study liver tissue microarchitecture and its heterogeneity in diseased states. This work aims to identify viable targets for the treatment of liver disease and metabolic dysfunction in humans.

I have also published on both existing and new biomarkers of liver fat and fibrosis in MASLD. My research has demonstrated the limited effectiveness of certain widely used fibrosis biomarkers in obese individuals, prompting changes in MASLD guideline recommendations. Recently, I established how magnetic resonance-derived liver fat measurements should be interpreted against conventional histological quantification of steatosis.

My current position is as a research fellow at the University of Helsinki and Minerva Foundation Institute for Medical Research. Recent clinical practice includes work as a resident in gastroenterology and hepatology at the Helsinki University Hospital. I have expertise in treating patients with gastrointestinal and hepatobiliary disorders as well as in endoscopic procedures.

Education/Academic qualification

Licentiate of Medicine (MD), University of Helsinki

External positions

Clinical Research Fellow, Minerva Foundation Institute for Medical Research

Fields of Science

  • 3121 General medicine, internal medicine and other clinical medicine
  • Metabolism
  • Endocrinology
  • Hepatology
  • Non-alcoholic fatty liver disease
  • Genetics

International and National Collaboration

Publications and projects within past five years.